ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

Shortfall In Centers Budget Threatens Grants Of Half Of The 17 Competing For Renewal In 1980

October 12, 1979

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981

House Plan Promises $3.5 Billion For NIH; Cooperative Groups May Get AHRQ Funds

January 23, 2009

NCI awards $7.3 Million for Studies In Cancer communications

October 15, 1993